Shares of Kura Oncology Inc. (NASDAQ:KURA) rose 6.7% during mid-day trading on Wednesday . The company traded as high as $4.95 and last traded at $4.43, with a volume of 835,984 shares trading hands. The stock had previously closed at $4.15.

KURA has been the topic of a number of research reports. Zacks Investment Research downgraded shares of Kura Oncology from a “buy” rating to a “hold” rating in a report on Tuesday, May 17th. Oppenheimer Holdings Inc. reiterated an “outperform” rating and issued a $16.00 price target on shares of Kura Oncology in a report on Tuesday, June 21st.

The company’s market cap is $80.77 million. The stock’s 50 day moving average price is $3.20 and its 200 day moving average price is $3.88.

Kura Oncology (NASDAQ:KURA) last issued its quarterly earnings results on Wednesday, May 11th. The company reported ($0.36) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.35) by $0.01. Analysts predict that Kura Oncology Inc. will post ($1.70) earnings per share for the current year.

Kura Oncology, Inc is a clinical-stage biopharmaceutical company. The Company is engaged in discovering and developing personalized therapeutics for the treatment of solid tumors and blood cancers. Its segment is engaged in the discovery and development of personalized therapeutics for the treatment of solid tumors and blood cancers.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.